Harbinger Medical (Eden Prairie, Minnesota) said that the FDA cleared its the Micro-Induction 1000 System, a high fidelity, active variance, electrocardiograph intended for use in stratifying the risk of cardiac disease patients. (Product Pipeline).(Brief Article)

* Harbinger Medical (Eden Prairie, Minnesota) said that the FDA cleared its the Micro-Induction 1000 System, a high fidelity, active variance, electrocardiograph intended for use in stratifying the risk of cardiac disease patients. In clinical studies at the University of Minnesota (St. Paul, Minnesota), the Mayo Clinic (Rochester, Minnesota) and Regional Hospital (Trondheim, Norway), the measurements and analyses performed by the Harbinger system assisted in the risk stratification of post-myocardial infarction (MI) …